Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis

Leukemia

Volumn 18, Issue 9, 2004, Pages 1505-1511

  Blin Wakkach, C ^a   Wakkach, A ^a   Sexton, P M ^b   Rochet, N ^a   Carle, G F ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

B lymphopoiesis; Hematopoiesis; Osteoclast; Osteopetrosis

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CD4 ANTIGEN; GAMMA INTERFERON; PROTON PUMP; INTERLEUKIN 7;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MASS; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE MODEL; GENE MUTATION; HEMATOLOGIC DISEASE; HEMATOPOIESIS; IMMUNE DEFICIENCY; LETHALITY; LYMPHOCYTE COUNT; LYMPHOPOIESIS; MICROENVIRONMENT; MOUSE; MOUSE STRAIN; MYELOPOIESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PRIORITY JOURNAL; RARE DISEASE; T LYMPHOCYTE ACTIVATION; ANIMAL; BONE MARROW; C3H MOUSE; C57BL MOUSE; COMPARATIVE STUDY; CYTOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SECRETION; SPLEEN; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; BONE MARROW; BONE RESORPTION; CELL DIFFERENTIATION; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HEMATOPOIESIS; INTERFERON TYPE II; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOCLASTS; OSTEOPETROSIS; SPLEEN; T-LYMPHOCYTES;

EID: 4444327642     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403449     Document Type: Article

References (37)

1. Lazner F, Gowen M, Pavasovic D, Kola I. Osteopetrosis and osteoporosis: two sides of the same coin. Hum Mol Genet 1999; 8: 1839-1846.
2. Wilson CJ, Vellodi A. Autosomal recessive osteopetrosis: diagnosis, management, and outcome. Arch Dis Child 2000; 83: 449-452.
3. McLean W, Olsen BR. Mouse models of abnormal skeletal development and homeostasis. Trends Genet 2001; 17: S38-S43.
4. Scimeca JC, Franchi A, Trojani C, Parrinello H, Grosgeorge J, Robert C et al. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 2000; 26: 207-213.
5. Nakamura I, Takahashi N, Udagawa N, Moriyama Y, Kurokawa T, Jimi E et al. Lack of vacuolar proton ATPase association with the cytoskeleton in osteoclasts of osteosclerotic (oc/oc) mice. FEBS Lett 1997; 401: 207-212.
6. Chalhoub N, Benachenhou N, Rajapurohitam V, Pata M, Ferron M, Frattini A et al. Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat Med 2003; 9: 399-406.
7. Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A et al. Loss of the CIC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001; 104: 205-215.
8. Frattini A, Pangrazio A, Susani L, Sobacchi C, Mirolo M, Abinun M et al. Chloride channel CICN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J Bone Miner Res 2003; 18: 1740-1747.
9. Cleiren F, Benichou O, Van Hul E, Gram J, Bollerslev J, Singer FR et al. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the CICN7 chloride channel gene. Hum Mol Genet 2001; 10: 2861-2867.
10. Kornak U, Schulz A, Friedrich W, Uhlhaas S, Kremens B, Voit T et al. Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet 2000; 9: 2059-2063.
11. Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 2000; 25: 343-346.
12. Sobacchi C, Frattini A, Orchard P, Porras O, Tezcan I, Andolina M et al. The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum Mol Genet 2001; 10: 1767-1773.
13. Scimeca JC, Quincey D, Parrinello H, Romatet D, Grosgeorge J, Gaudray P et al. Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis. Hum Mutat 2003; 21: 151-157.
14. Lemieux ME, Rebel VI, Lansdorp PM, Eaves CJ. Characterization and purification of a primitive hematopoietic cell type in adult mouse marrow capable of lymphomyeloid differentiation in long-term marrow 'switch' cultures. Blood 1995; 86: 1339-1347.
15. Quinn JM, Morfis M, Lam MH, Elliott J, Kartsogiannis V, Williams ED et al. Calcitonin receptor antibodies in the identification of osteoclasts. Bone 1999; 25: 1-8.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
17. Osmond DG, Rolink A, Melchers F. Murine B lymphopoiesis: towards a unified model. Immunol Today 1998; 19: 65-68.
18. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003; 18: 605-617.
19. Lee SK, Kalinowski JF, Jastrzebski SL, Puddington L, Lorenzo JA. Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis. Endocrinology 2003; 144: 3524-3531.
20. Green P, Marshall M, Nisbet N. A study of osteoclasts on calvaria of normal and osteopetrotic (mi/mi) mice by vital staining with acridine orange. Br J Exp Pathol 1986; 67: 85-93.
21. Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 1992; 90: 1622-1627.
22. Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999; 13: 2412-2424.
23. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999; 397: 315-323.
24. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD et al. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev 1997; 11: 3482-3496.
25. Taranta A, Migliaccio S, Recchia I, Caniglia M, Luciani M, De Rossi G et al. Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am J Pathol 2003; 162: 57-68.
26. Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, Takatsu K et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 1999; 4: 353-362.
27. Tagaya H, Kunisada T, Yamazaki H, Yamane T, Tokuhisa T, Wagner EF et al. Intramedullary and extramedullary B lymphopoiesis in osteopetrotic mice. Blood 2000; 95: 3363-3370.
28. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990; 345: 442-444.
29. Jacobsen K, Osmond DG. Microenvironmental organization and stromal cell associations of B lymphocyte precursor cells in mouse bone marrow. Eur J Immunol 1990; 20: 2395-2404.
30. Grcevic D, Katavic V, Lukic I, Kovacic N, Lorenzo J, Marusic A. Cellular and molecular interactions between immune system and bone. Croat Med J 2001; 42: 384-392.
31. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995; 181: 1519-1526.
32. Stephan RP, Reilly CR, Witte PL. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 1998; 91: 75-88.
33. Fleming HE, Paige CJ. Cooperation between IL-7 and the pre-B cell receptor: a key to B cell selection. Semin Immunol 2002; 14: 423-430.
34. Godfrey DI, Zlotnik A. Control points in early T-cell development. Immunol Today 1993; 14: 547-553.
35. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 2000; 408: 600-605.
36. Utku N, Heinemann T, Tullius SG, Bulwin GC, Beinke S, Blumberg RS et al. Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein. Immunity 1998; 9: 509-518.
37. Driessen GJ, Gerritsen EJ, Fischer A, Fasth A, Hop WC, Veys P et al. Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant 2003; 32: 657-663.